Error: Could not add to watchlist. X

Tekla Healthcare Investors

+ Watchlist
XHQHX:US
NASDAQ GM
32.81
USD
0.50
1.50%
As of 20:01:21 ET on 09/03/2015.
Fund Type
Closed-End Fund
52Wk Range
27.52 - 37.63
1 Yr Return
21.97%
YTD Return
10.41%
Open
32.81
Day Range
32.81 - 32.81
Previous Close
33.31
52Wk Range
27.52 - 37.63
1 Yr Return
21.97%
YTD Return
10.41%
Fund Type
Closed-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 09/03/2015)
32.81
Total Assets (b USD) (on 06/26/2015)
1.308
Inception Date
04/22/1987
Last Dividend (on 08/26/2015)
0.71
Dividend Indicated Gross Yield
8.66%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
0.95%
Expense Ratio
1.13%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 997.39 k 116.77 m 8.94
Celgene Corp 993.77 k 115.01 m 8.81
Allergan plc 252.90 k 76.75 m 5.88
Regeneron Pharmaceuticals Inc 132.64 k 67.67 m 5.18
Biogen Inc 163.46 k 66.03 m 5.06
Mylan NV 916.39 k 62.19 m 4.76
Vertex Pharmaceuticals Inc 474.88 k 58.64 m 4.49
BioMarin Pharmaceutical Inc 406.55 k 55.61 m 4.26
Alexion Pharmaceuticals Inc 297.31 k 53.74 m 4.11
Incyte Corp 508.32 k 52.97 m 4.06
Profile
Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500